146 related articles for article (PubMed ID: 29332602)
1. Nanoemulsion Strategy for Ursolic and Oleanic Acids Isolates from
Alvarado HL; Calpena AC; Garduño-Ramírez ML; Ortiz R; Melguizo C; Prados JC; Clares B
Anticancer Agents Med Chem; 2018; 18(6):847-853. PubMed ID: 29332602
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a high-performance liquid chromatography method for the quantification of ursolic/oleanic acids mixture isolated from Plumeria obtusa.
Alvarado HL; Abrego G; Garduño-Ramirez ML; Clares B; García ML; Calpena AC
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():111-6. PubMed ID: 25638028
[TBL] [Abstract][Full Text] [Related]
3. The chemical and biological potential of C ring modified triterpenoids.
Siewert B; Wiemann J; Köwitsch A; Csuk R
Eur J Med Chem; 2014 Jan; 72():84-101. PubMed ID: 24361521
[TBL] [Abstract][Full Text] [Related]
4. Selective in vitro anti-melanoma activity of ursolic and oleanolic acids.
Oprean C; Ivan A; Bojin F; Cristea M; Soica C; Drăghia L; Caunii A; Paunescu V; Tatu C
Toxicol Mech Methods; 2018 Feb; 28(2):148-156. PubMed ID: 28868958
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
6. Improvement of ursolic and oleanolic acids' antitumor activity by complexation with hydrophilic cyclodextrins.
Oprean C; Mioc M; Csányi E; Ambrus R; Bojin F; Tatu C; Cristea M; Ivan A; Danciu C; Dehelean C; Paunescu V; Soica C
Biomed Pharmacother; 2016 Oct; 83():1095-1104. PubMed ID: 27551755
[TBL] [Abstract][Full Text] [Related]
7. Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: In vitro and in vivo assays.
Caunii A; Oprean C; Cristea M; Ivan A; Danciu C; Tatu C; Paunescu V; Marti D; Tzanakakis G; Spandidos DA; Tsatsakis A; Susan R; Soica C; Avram S; Dehelean C
Int J Oncol; 2017 Dec; 51(6):1651-1660. PubMed ID: 29039461
[TBL] [Abstract][Full Text] [Related]
8. The effect of ursolic and oleanolic acids on human skin fibroblast cells.
Wójciak-Kosior M; Paduch R; Matysik-Woźniak A; Niedziela P; Donica H
Folia Histochem Cytobiol; 2011; 49(4):664-9. PubMed ID: 22252762
[TBL] [Abstract][Full Text] [Related]
9. Dual activity of triterpenoids: apoptotic versus antidifferentiation effects.
Cipak L; Grausova L; Miadokova E; Novotny L; Rauko P
Arch Toxicol; 2006 Jul; 80(7):429-35. PubMed ID: 16496127
[TBL] [Abstract][Full Text] [Related]
10. Novel 3-oxo- and 3,24-dinor-2,4-secooleanane-type triterpenes from Terminalia ivorensis A. Chev.
Ponou BK; Teponno RB; Ricciutelli M; Nguelefack TB; Quassinti L; Bramucci M; Lupidi G; Barboni L; Tapondjou LA
Chem Biodivers; 2011 Jul; 8(7):1301-9. PubMed ID: 21766451
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis Caused by Triterpenes and Phytosterols and Antioxidant Activity of an Enriched Flavonoid Extract from Passiflora mucronata.
da Silva ICV; Kaluđerović GN; de Oliveira PF; Guimarães DO; Quaresma CH; Porzel A; Muzitano MF; Wessjohann LA; Leal ICR
Anticancer Agents Med Chem; 2018; 18(10):1405-1416. PubMed ID: 29542423
[TBL] [Abstract][Full Text] [Related]
12. Enhancing anticancer activity through the combination of bioreducing agents and triterpenes.
Bednarczyk-Cwynar B; Ruszkowski P; Jarosz T; Krukiewicz K
Future Med Chem; 2018 Mar; 10(5):511-525. PubMed ID: 29424550
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization.
Alvarado HL; Abrego G; Souto EB; Garduño-Ramirez ML; Clares B; García ML; Calpena AC
Colloids Surf B Biointerfaces; 2015 Jun; 130():40-7. PubMed ID: 25899842
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of ursolic acid and oleanolic acid in leukemic cells.
Ovesná Z; Kozics K; Slamenová D
Mutat Res; 2006 Aug; 600(1-2):131-7. PubMed ID: 16831451
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.
Alvarado HL; Abrego G; Garduño-Ramirez ML; Clares B; Calpena AC; García ML
Nanomedicine; 2015 Apr; 11(3):521-30. PubMed ID: 25659643
[TBL] [Abstract][Full Text] [Related]
17. Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid.
Yin MC; Chan KC
J Agric Food Chem; 2007 Aug; 55(17):7177-81. PubMed ID: 17658830
[TBL] [Abstract][Full Text] [Related]
18. Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment.
Jiménez-Arellanes A; Luna-Herrera J; Cornejo-Garrido J; López-García S; Castro-Mussot ME; Meckes-Fischer M; Mata-Espinosa D; Marquina B; Torres J; Hernández-Pando R
BMC Complement Altern Med; 2013 Oct; 13():258. PubMed ID: 24098949
[TBL] [Abstract][Full Text] [Related]
19. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of triterpene acids and semi-synthetic derivatives against oral pathogens.
Scalon Cunha LC; Andrade e Silva ML; Cardoso Furtado NA; Vinhólis AH; Martins CH; da Silva Filho AA; Cunha WR
Z Naturforsch C J Biosci; 2007; 62(9-10):668-72. PubMed ID: 18069238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
